Skip to main content

Anchorsure® System

The Anchorsure® System (Neomedic International; distributed in the UK / Europe by JUNE Medical) is a PEEK anchor-based device (ABD) for sacrospinous ligament fixation (SSLF) in apical pelvic-organ-prolapse repair. Mechanistically distinct from suture-capturing devices like the Capio: rather than passing a suture through the ligament, the Anchorsure deploys a small biocompatible anchor into the sacrospinous ligament substance, with the apical-support suture pre-attached. Particularly suited to the anterior approach to the sacrospinous ligament, where suture-capturing devices are more technically demanding.[1][2]

Design

  • Straight, narrow delivery device for atraumatic transvaginal introduction.
  • PEEK (polyetheretherketone) anchor — 100% biocompatible polymer, permanently implanted.
  • Pre-attached suture on the anchor.
  • Tactile feedback during ligament engagement — signals correct anchor seating.
  • Native-tissue (mesh-free) fixation system.[3]

Rationale — Anchor vs Suture Capture

Traditional suture-based SSLF requires tight suture knots around or through the ligament, which may:

  • Compress or compromise neurovascular structures (pudendal nerve, inferior gluteal vessels)
  • Contribute to gluteal / buttock pain — the characteristic SSLF complication
  • Depend on ligament tissue quality to hold the knot long-term

The anchor-based approach embeds fixation within the ligament substance rather than encircling it — theoretically reducing the risk of neurovascular compression and related pain.

Reconstructive / Urogyn Uses

  • Vaginal vault prolapse after hysterectomy — apical suspension
  • Uterovaginal prolapse with sacrospinous fixation (Amreich–Richter technique)
  • Post-hysterectomy vault prolapse repair
  • Anterior approach to SSLF — the niche where Anchorsure's mechanical advantage over suture-capturing devices is largest[1]

Efficacy

EndpointResultSource
Sexual function at 3 mo (FSFI total score)19.15 → 21.84 (p < 0.05) in 115 women undergoing SSLS with AnchorsureAhmadian 2026 prospective multicenter[3]
Objective / subjective cure rates90–95% in 676-patient series (19 Anchorsure alone, remainder Anchorsure + transvaginal mesh)Lo 2025[4]

Complications

ComplicationRate / FindingSource
Day-1 postoperative painSlightly higher with ABD (3.40 vs 1.60 SCD, p = 0.013); mean highest pain score similar overallEvangelopoulos 2024 pilot case-control (n = 40)[1]
Gluteal / posterior-thigh pain at 1 wk, 6 wkNo significant difference vs CapioPlair 2022 RCT[2]
Opioid use postoperativelySimilar to CapioPlair 2022 RCT[2]
Prolapse symptom scoresSimilar to CapioPlair 2022 RCT[2]
Tacker dislodgement2.2% of 676 cases; sequelae included 2 bladder injuries + 4 operator injuries (glove tears / finger cuts); higher BMI and HTN associated with dislodgement riskLo 2025[4]
Nerve-injury rateLower than Capio in pooled meta-analytic dataAmiri 2024 SR + meta-analysis[5]
Reoperation rateSlightly higher than some suture-capturing devices; overall complication rates remain low across all devicesAmiri 2024 SR + meta-analysis[5]

The Lo 2025 tacker-dislodgement signal is the most important contemporary caveat for surgeon technique: 2.2% dislodgement in a large cohort, with the operator-injury complication (glove tears / finger cuts) being a recurring theme. Two bladder injuries from dislodged anchors underscore the need for cystoscopy after deployment.

Anchorsure vs Capio — Head-to-Head Comparison

FeatureAnchorsure (Anchor-Based)Capio (Suture-Capturing)
MechanismDeploys anchor into SSL substancePasses suture through SSL
Gluteal / posterior-thigh painNo significant difference vs Capio[2]No significant difference vs Anchorsure[2]
Day-1 postop painSlightly higher (3.40 vs 1.60)[1]Slightly lower[1]
Nerve-injury rateLower than Capio[5]Highest pooled rate (3.8%)[5]
Reoperation rateSlightly higher[5]Lower[5]
Anterior approach to SSLWell-suited[1]More technically challenging[1]
Device-specific failure modeTacker dislodgement 2.2% (Lo 2025)[4]Pooled nerve-injury 3.8% (Amiri 2024)[5]

The two devices are broadly equivalent for the primary outcomes (cure, gluteal pain) — the anterior-vs-posterior surgical approach and surgeon comfort drive most of the choice.[1][2]

Context Within POP Surgery

SSLF overall has slightly lower anatomical success than abdominal sacrocolpopexy (88% vs 91%) but offers shorter operative times, lower hemorrhage rates, and fewer GI complications — making it a durable native-tissue option for the patient who prefers a vaginal approach.[6] Within the SSLF instrument family, the choice between anchor-based (Anchorsure, Saffron) and suture-capturing (Capio, Endostitch, i-Stitch) devices is largely surgeon preference + approach geometry, since outcomes and complication profiles are broadly comparable.[1][2]

Regulatory / Commercial Status

  • FDA-approved in the United States
  • CE-marked in Europe
  • Commonly distributed alongside the Uplift sacrocolpopexy mesh for laparoscopic prolapse repair (separate product family)

See also: Capio Suture Capturing Device, Saffron Fixation System, i-Stitch, Endostitch, Miya Hook, Deschamps Ligature Carrier.


References

1. Evangelopoulos N, Delacroix C, Abdirahman S, de Tayrac R. "Safety of an anchor-based device for sacrospinous ligament fixation: a pilot case-control study." Eur J Obstet Gynecol Reprod Biol. 2024;299:105–109. doi:10.1016/j.ejogrb.2024.06.012

2. Plair A, Smith W, Hines K, et al. "Gluteal and posterior thigh pain from a suture compared with an anchor-based device in patients undergoing sacrospinous ligament fixation: a randomized controlled trial." Obstet Gynecol. 2022;139(1):97–106. doi:10.1097/AOG.0000000000004629

3. Ahmadian N, Rastkar E, Amiri E, Bastani P, Sattarpour R. "Sexual function after Anchorsure repair of sacrospinous ligament suspension in patients with pelvic organ prolapse: a prospective multicenter study." Sci Rep. 2026. doi:10.1038/s41598-026-52719-w

4. Lo TS, Rellora LE, Yu CC, Ro AL, Yang CH. "Operator and patient injuries from tacker dislodgement during sacrospinous ligament fixation: a retrospective study." BJOG. 2025. doi:10.1111/1471-0528.70089

5. Amiri E, Bastani P, Mallah F, Mostafaei H, Salehi-Pourmehr H. "Comparison of the complications rate of different suture-passing techniques at the time of sacrospinous ligament fixation: a systematic review and meta-analysis." Arch Gynecol Obstet. 2024;310(6):2791–2809. doi:10.1007/s00404-024-07788-5

6. Zhang W, Cheon WC, Zhang L, et al. "Comparison of the effectiveness of sacrospinous ligament fixation and sacrocolpopexy: a meta-analysis." Int Urogynecol J. 2022;33(1):3–13. doi:10.1007/s00192-021-04823-w